Role of Linagliptin in Type 2 Diabetes Mellitus Therapy: An Indian Perspective

Abstract

Given the rising prevalence and significant health and economic burdens associated with type 2 diabetes mellitus (T2DM)
globally, especially in low- and middle-income countries, exploring effective treatment options is crucial. In this review, we
have reviewed the role of linagliptin therapy in managing T2DM in the Indian context. The review specifically delves into
the pharmacokinetic and pharmacodynamic properties of linagliptin, emphasizing its potential benefits in the context of the
unique characteristics of Asian T2DM patients. The study provides valuable insights into the strategic use of linagliptin in
the treatment landscape of T2DM, offering a comprehensive and all-encompassing approach to its clinical implications in
various patient settings.